drugset / Trial / NCT04676763

Substance P Challenge in Healthy Participants

NCT04676763

Completed 32 enrolled GlaxoSmithKline
Non-randomizedSequentialOpen-labelOther

Summary

The objectives of this enabling study are to characterize the wheal and flare responses over time following skin challenges with ascending concentrations of Substance P. This will be a 2-part study: Part 1 will aid in the understanding of the wheal and flare responses following Substance P. Part 2 will investigate the variability of the responses. Participants may be enrolled into Part 1 or Part 2, not both.

Timeline

Start
2021-03-02
Primary completion
2021-07-21
Completion
2021-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Substance P Small molecule Other
Background Histamine Small molecule

Indications